A GREAT BOOK ON TAU BIOLOGY
Twitter: @LucBuee

EUROTAU WILL BE HELD ON OCTOBER 25-26, 2021

.

See our New Eurotau website

 

THE RAINWATER PRIZE 2020

              

WHO WILL BE THE 2021 PRIZE ?

NEWS (click for older news)
Lab VIDEOS
ARTICLES RECENTS / RECENT PUBLICATIONS
 
Brain network remodelling reflects tau-related pathology... - 2020 Brain
 
Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction & memory deficits in Alzheimer’s disease - 2020 Nature Neuroscience
 
NRLP3, tau and amyloid cascade - Nature 2019
 
New review on prion-like tau propagation - Acta Neuropathol 2020
 
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor Brain
 
Current & emerging avenues for Alzheimer's disease drug targets. J Intern Med
 
Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain
 
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? Acta Neuropathol Commun
 
A walk through tau therapeutic strategies. Acta Neuropathol Commun
 
Different Tau species lead to heterogeneous Tau pathology propagation and misfolding. Acta Neuropathol Commun
L'équipe "Alzheimer & Tauopathies" vous souhaite la bienvenue sur sa page d'accueil. Vous souhaitez mieux nous connaître: c'est ICI
 
Welcome on the "Alzheimer & Tauopathies" home webpage. More information HERE
Recent and future Seminars
Eléonore Maury (UCLouvain) Molecular basis of Circadian Desynchrony in cardiometabolic and neurodegenerative diseases. November 6, 2019 - 3:30pm
 
Nicole Déglon (Lausanne, CH) Genetic engineering to the rescue of Huntington's disease. October 14, 2019 - 10:30am
 
Delphine Boche (Southampton, UK) Microglia: the key cells for tau pathology. September 27, 2019 - 2:00pm
 
Frederic Checler (Valbonne, France) Presenilins-PINK1 functional interplay governs mitophagic response. September 13, 2019 - 11:00am
 
Diane P Hanger (London, UK) The damaging effects of truncated tau in cell and animal models of human tauopathy. July 1, 2019 - 2:30pm
 
Detlef Balschun (Leuven, Belgium) The synapse as pathological hotspot in neurodegeneration - an electro-physiological approach. March 22, 2019 - 11:00am
 
Rodrigo Cunha (Coimbra, Portugal) Role of adenosine A2A receptor in the control of mood. February 1, 2019 - 11:00am.
 
Franck Martin (Strasbourg) The molecular basis of the ribosome code. January 29, 2019 - 2:00pm.
 
Diana F Lazaro (Göttingen, Sweden)  Deciphering the role of synphilin-1 on Parkinson's disease. October 31, 2018 - 2:00pm
 
Eric Boué-Grabot (Bordeaux) Implication of P2X receptors in synaptic plasticity and memory. September 24, 2018 - 3:00pm
 
Gabor Petzold (Bonn Germany) Role of astrocyte purinergic signaling in Alzheimer’s disease. September 5, 2018 - 3:00pm
 
Fabien Delahaye (AECOM, NY) From Discovery to Cellular Mechanism: Functional Genomics 2.0. September 3, 2018 - 11:00am
 
Cécile Delarasse (Paris) New role of P2X7 receptor in Alzheimer's disease. July 23, 2018 - 11:00am
 
EUROTAU2018. Lille, France. April 26-27, 2018.
 
Christian Hackenberger (Berlin, Germany) The power of chemo-selectivity – Functional antibody conjugates for intra- and extracellular targeting. March 2, 2018 - 11:00 am
 
Michael Heneka (Bonn, Germany) Immunity in Alzheimer's disease. February 16, 2018 - 11:00 am
 
Kunie Ando (Bruxelles) The role of PICALM in Tau pathology progression. February 6, 2018 - 2:00 pm.
 
Alain Cappy (IEMN, Villeneuve d'Ascq) Energy efficient artificial neural circuits. December 21, 2017 - 11:00 am
 
Thierry Galli (CPN, Paris) Conventional and unconventional secretory mechanisms in neuronal development. November 21, 2017 - 11:30 am
 
Giovanni Stevanin (ICM, Paris). Apport de la nouvelle génération de séquençage dans les dégénérescences cérébelleuses. October 20, 2017 - 11:00 am
 
Taxiarchis Katsinelos (Heidelberg, Germany) Unconventional secretion mediates the trans-cellular spreading of tau. September 28, 2017 - 3:00 pm
 
Tiago F Outeiro (Göttingen, Germany) Thinking beyond the nigra: alpha-synuclein mediated synaptic functions in the hippocampus. September 22, 2017 - 10:00 am.
 
Pietro Fazzari (Madrid, Spain) NRG1-schizophrenia risk gene: excitatory inhibitory balance in cortical circuits. September 21, 2017. 10:00 am.
 
Jens Brüning (Köln, Germany) CNS pathways in control of glucose metabolism. July 20, 2017 - 3:00 pm
 
Khalid Iqbal (IBR, Staten Island, USA) Prenatal to early postnatal treatment of Down syndrome and Alzheimer disease in animal models. July 11, 2017 - 12:30 pm
 
Silvia Bolognin (Luxembourg) The potential role of Rho-GTPases in the aetiology of Alzheimer’s Disease. July 11, 2017 - 11:00 am
 
Flavio Giorgini (University of Leicester, UK) "The kynurenine pathway and neurodegeneration: from mechanisms to therapeutics". July 7, 2017 - 11:00 am
 
L. de Lecea (Stanford University, USA) "To sleep or not to sleep: how the brain decides between vigilance states" June 30, 2017 - 11:00 am
 
Khalid Iqbal (IBR, Staten Island, USA) "Tau immunization and neuroregeneration: attempting treatment from both ends" June 29, 2017 - 2:00 pm
 
Maud Gratuze (Quebec, Canada) Impact of type 2 diabetes and obesity on phosphorylation of the tau protein in db/db and ob/ob mouse models: role of hypothermia. June 9, 2017 - 11:00 am
 
Luisa Lopes (Lisbon, Portugal) Caffeine analogs in age related memory deficits - insights from animal models. June 8, 2017 - 2:30 pm
 
Anne-Laurence Boutillier (Strasbourg) Epigenetic correction of defective plasticity in a mouse model of Tauopathy with an acetyltransferase activator, June 7, 2017 - 11:30 am
 
Florent Laferrière (Zürich, CH) Caractérisation des agrégats pathologiques de TDP-43 dans l'ALS et les FTD. June 2, 2017 - 2:00 pm
 
Thibault Honegger (Grenoble, F) Neurofluidics. May 12, 2017.
 
The EuroTau meeting, April 27-28, 2017
 
Sergi FERRE (Baltimore, NIH, USA) Allosterism within GPCR oligomers: back to symmetry. April 6, 2017 - 11:00 am
 
Martin DENZEL (Köln, Germany) Hexosamine pathway activation improves protein homeostasis and extends lifespan. March 17, 2017 - 3:00 pm
 
Jérémy TERRIEN (Brunoy, F) The grey mouse lemur. February 23, 2017
 
Didier VIEAU (Lille, F) L'environnement périnatal joue-t-il un rôle dans la maladie d'Alzheimer. October 14, 2016 - 1:30 pm
 
Sandrine HUMBERT (GIN, Grenoble) Huntingtin regulates cortical development: consequences for Huntington’s disease. October 4, 2016 - 2:00 pm
 
Raphaëlle PARDOSSI (IPMC, France) C99 and AICD involvement in Alzheimer's disease. Sept 20, 2016 - 4:00 pm
 
Thierry GALLI (Institut J Monod & CPN, Paris) Membrane trafficking and neuronal differentiation. Sept 19, 2016 - 11:00 am
 
Yijuang CHERN (Taipei Medical Univ.)  A central role of TRAX in the ATM-mediated DNA repair during elevated oxidative stress. July 13, 2016 - 2:00 pm
 
Frank YATES (SupBioTech) Organoïdes neuroectodermiques: des mini-cerveaux pour modéliser les maladies neurodégénératives? July 7, 2016 - 3:00 pm
 
Christophe MAGNAN (Univ Paris Diderot) Rôle de la détection centrale des lipides dans le contrôle nerveux de la dépense énergétique. May 9, 2016 - 2:00 pm
 
Luc BUEE (Univ. Lille, F) Les maladies neurodégénératives sont-elles contagieuses? April 29, 2016, 1:00 pm
 
Patricia MELNYK (Univ. Lille, F) AZP2006, un candidat médicament pour la maladie d'Alzheimer. April 1, 2016, 1:00 pm
 
David BLUM (Univ. Lille, F) Caffeine is not a drug, it's a vitamin. March 18, 2016, 1:00 pm
 
Sophie HALLIEZ (Jacques Monod Institute - CNRS, Paris) The Prion Protein in all its forms. March 14, 2016 - 2:00 pm
 
Sébastien SART (CNRS, Ecole Polytechnique, Palaiseau) Regulation and Monitoring of Cellular Functions in 3D Spheroids. February 23, 2016 - 2:00 pm
 
Frank Lafont, Gabriele Kaminski (Cambridge, UK), Sylvain Gabriele (Mons, Be), Jerome Clasadonte, Vincent Thomy, Fabien Alibart, Morvane Colin. New technologies and Neurosciences: Electrophysiology, High resolution microscopy, Light-sheet microscopy, Mem-resistors, Microfluidics...: November 16, 2015
 
Hélène TRAN (University of Massachusetts Medical School, USA) RNA versus Protein Mediated Toxicity of C9ORF72 Repeat Expansion: Insights from a Drosophila Model. September 30, 2015
 
Catherine MARQUER (Columbia University Medical Center, New York City, USA) Novel role for the small GTPase Arf6 in the control of retromer trafficking, a key player in neurodegenerative diseases. September 24, 2015 - 2:00 pm
 
Yijuang CHERN (Taipei, Taiwan) AMPK and metabolic dysfunction in amyotrophic lateral sclerosis. June 9, 2015 - 11:00 am
McCULLOUGH L Farmington CT USA. BEZARD E, Bordeaux F; THOMASON M, Detroit MI USA; ANTHONY D, Oxford UK; BRAININ M, Krems Austria; KALARIA R Newcastle UK. DN2M meeting. "Cognitive disorders : from neuron to society" June 5-6, 2015, Lille, France
Kim TIEU (Plymouth, UK) Targeting mitochondrial dynamics as a potential therapeutic treatment for Parkinson's disease and other neurodegenerative disorders. April 10, 2015 - 11:00 am
Gerd MULTHAUP (Montreal, Canada) Aß42 oligomer interacting peptides neutralize toxic Aß42 species and suppresse fibril formation. March 16, 2015 - 11:00 am
Claudia MARINANGELI (Lille, France) Role of presenilin transmembrane domain interactions in gamma-secretase activity and characterization of natural inhibitors. Feb. 24, 2015 - 2:00 pm
Giuseppe GANGAROSSA (Paris, France) The dopaminoceptive brain: from cell-type specific events to behavior. Feb. 17, 2015 - 2:00 pm
Claire RAMPON (Toulouse, France) Maladie d'Alzheimer et neurogenèse hippocampique: A la croisée des chemins. Feb. 6, 2015 - 11:00am
Hubert HONDERMARCK (Callaghan, Australia) Nerve-Cancer Cell Crosstalk: a Novel Promoter of Tumor Progression. Jan. 20, 2015
John STEELE (Guam, US) Progressive supranuclear palsy. October 13, 2014 - 5:00pm
Dominique WEIL (Paris) P-bodies in mRNA storage and degradation. October 10, 2014 - 10:00am
Selina WRAY (London, UK) Stem cell models of frontotemporal dementia. June 16, 2014 - 11:00am
Tiago OUTEIRO (Göttingen G) From the baker to the bedside: unraveling the molecular basis of Parkinson's disease. April 7, 2014
Khalid IQBAL (Staten Island NYC) “Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer disease”. March 24, 2014 - 10:30 am
Frédéric CHECLER (Valbonne, F) Parkin transcriptional targets and neurodegenerative disorders. March 18, 2014 - 11:00am
Florence CLAVAGUERA (Basel Switzerland) Transmission and spreading of Tauopathy in transgenic mice. December 16, 2013 - 4:15pm
Sébastien HEBERT (QC Canada) micro-RNAs and dementia - version 2.0. October 17, 2013 - 10:00am
ALSO FOLLOW US ON FACEBOOK https://www.facebook.com/groups/AlzTau/
"Cras elementum ultrices diam."
A service on your city
Alzheimer & Tauopathies - Luc Buée
Copyright 2020
About - Links - Contacts